GovWire

Guidance: Medicines eligible for Northern Ireland MHRA Authorised Route

Department Of Health

November 1
15:58 2024

class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Updates to this page

Published 16 December 2021
Last updated 1 November 2024 +show all updates
  1. Updated to add and remove products from the list. Added: Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes; Methotrexate 20mg/2ml solution for injection pre-filled syringes; Fluorouracil 2.5g/50ml solution for infusion vials; and Elfabrio 5mg/2.5ml concentrate for solution for infusion vials (Pegunigalsidase alfa 5mg/2.5ml solution for infusion vials). Removed: Doxorubicin 2mg/ml concentrate for solution and Temodal 100mg capsules (Temozolomide 100mg capsules).

  2. Added: Flucloxacillin 1g powder for solution for injection vials.

  3. Added: Artesunate 110 mg powder and solvent for solution for injection vials.

  4. Updated to add products to the list. Added Riociguat 2mg tablets; Riociguat 2.5mg tablets; Zanamivir 200mg/20ml solution for infusion vials.

  5. Updated to add: Doxorubicin 2mg/ml concentrate for solution.

  6. Updated to add and remove products from the list. Added: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials. Removed: Comirnaty Omicron XBB.1.5 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection single dose vials; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.

  7. Updated to add: Temodal 100mg capsules - Temozolomide 100mg capsules.

  8. Updated to add products to the list. Added: Duaklir 340micrograms/dose / 12micrograms/dose Genuair - Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler; LysaKare 25g/25g/1litre infusion bags - Arginine 25g/1litre / Lysine 25g/1litre infusion bags; Briviact 10mg/ml oral solution - Brivaracetam 50mg/5ml oral solution sugar free; and Remsima 120mg/1ml solution for injection pre-filled pens - Infliximab 120mg/1ml solution for injection pre-filled disposable devices.

  9. Updated to add: Rozlytrek 200mg capsules - Entrectinib 200mg capsules.

  10. Updated to add: Rozlytrek 100mg capsules - Entrectinib 100mg capsules.

  11. Updated to add: Fabhalta 200mg capsules - Iptacopan Hydrocloride Monohydrate 200mg capsules.

  12. Updated to add and remove products. Added: Colobreathe 1,662,500 unit inhalation powder capsules - Colistimethate 1,662,500unit inhalation powder capsules; and Spikevax JN.1 0.1 mg/mL dispersion for injection mRNA-1273.167 - COVID-19 mRNA vaccine. Removed: Brivaracetam 75mg tablets.

  13. Updated to add and remove products. Added: Pegasys 90micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 90micrograms/0.5ml solution for injection pre-filled syringes; Remsima 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for concentrate for solution for infusion vials; Truxima 500mg/50ml concentrate for solution for infusion vials - Rituximab 500mg/50ml concentrate for solution for infusion vials. Removed: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials.

  14. Updated to add products to the list. Added: Eklira 322micrograms/dose Genuair - Aclidinium bromide 375micrograms/dose dry powder inhaler; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.

  15. Updated to add and remove products. Added: Truxima 100mg/10ml concentrate for solution for infusion vials - Rituximab 100mg/10ml solution for infusion vials; Yuflyma 40mg/0.4ml solution for injection pre-filled pens - Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices; Oseltamivir 30mg capsules; Oseltamivir 45mg capsules; Oseltamivir 75mg capsules; and Dacarbazine 1g powder for solution for infusion vials. Removed: Zonegran 25mg capsules - Zonisamide 25mg capsules.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: